Long-term protection study after EV71 vaccination
Part of Infections clinical trials.
This study checks how long immunity lasts after receiving two doses of the EV71 vaccine. It is for children who took part in the earlier study and got either the vaccine or a placebo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were part of the earlier EV71 vaccine study and received either both vaccine doses or placebo.
- You must provide valid ID and have a parent or guardian who can understand and sign the consent form.
- You have not received any extra EV71 vaccine shots beyond the study.
- You have never had hand-foot-mouth disease.
- You are not currently in any other research study.
- You do not have a bleeding disorder or take blood thinners.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests three batches of an EV71 vaccine (which prevents hand, foot, and mouth disease) to see if they work the same. Your child would receive two doses, several weeks apart, and have blood tests to check their immune response.
This study tests an EV71 vaccine in healthy children aged 6 to 71 months. The vaccine aims to protect against hand, foot, and mouth disease caused by the EV71 virus.
This trial tests a new two-in-one vaccine to protect children against hand, foot, and mouth disease caused by two common viruses (EV71 and CA16). It is for healthy kids ages 6 months to 5 years and will check if the vaccine is safe and works well.
This study tests a new vaccine that protects against four types of enterovirus (EV71, CA16, CA10, CA6) that cause hand, foot, and mouth disease. Researchers want to see if the vaccine is safe and effective in young children ages 6 months to 6 years.
This trial tests a vaccine that targets two viruses causing hand, foot, and mouth disease. It aims to see if the vaccine is safe and effective for people aged 6 months to 59 years.
This study simply watches children with hand, foot, and mouth disease or herpangina to learn more about these illnesses. Your child's regular care won't change, and no extra treatments are given.
Hear when a new Hand, Foot and Mouth Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.